Standard Biotools | FLDM - Current Liabilities

Stock Price
1.14
Daily Change
0.01 0.44%
Monthly
-25.82%
Yearly
-14.66%
Q1 Forecast
1.09

Standard Biotools reported $107.96M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Becton, Dickinson and Co. USD 8.76B 448M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Danaher USD 6.81B 483M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Myriad Genetics USD 148M 51.9M Sep/2025
Nikon Corporation JPY 368.38B 30.3B Dec/2025
Pacific Biosciences Of California USD 63.21M 3.45M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sony JPY 5.16T 20.87T Dec/2025
Standard Biotools USD 107.96M 9.94M Sep/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Waters USD 1.24B 11.8M Dec/2025